amertz @ acla . com
Alan Mertz became the President of ACLA in 2003. During his tenure as President, ACLA’s membership has grown, the organization has greater visibility in Congress and the Administration, and ACLA’s advocacy programs have been successful.
During Mr. Mertz’s tenure, ACLA has become a leader on advocacy issues dealing with laboratory reimbursement, regulation and coding. On reimbursement, ACLA was instrumental in stopping legislation that would have instituted coinsurance for laboratory services in Medicare, in repealing the Medicare Competitive Bidding Demonstration program, and heading off a proposal for imposing a new federal tax on all laboratory revenue. ACLA also led the successful campaign to modify the “physician signature” requirement that was proposed by Medicare.
On the regulatory front, ACLA is recognized as being in the forefront of advocacy efforts to ensure that regulatory changes do not stifle innovation in genetic and molecular testing. ACLA has also been a leader on molecular coding and reimbursement issues.
In 2007, ACLA launched the “Results for Life” educational campaign aimed at promoting the value of laboratory services. In 2009, ACLA started its Associate Member program for non-laboratory health care companies and organizations as a means of broadening education and communication with the laboratory industry’s health partners.
From 1998-2003, Mertz was Executive Vice President and Acting President of the Healthcare Leadership Council (HLC), and from 1980 to 1998 served in three senior staff positions in the House and Senate. He was selected as a John C. Stennis Congressional Fellow in 1996, taught as an adjunct professor at George Washington University from 1997-1999, and is a frequent lecturer at American University in Washington, DC. He holds a Masters Degree in American Politics from American University and a BA in Government from Monmouth College.